Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II

NCT02592824 is registered in ClinicalTrials.gov with University Hospital, Linkoeping as lead sponsor.

NCT NCT02592824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02592824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II
Lead sponsor
University Hospital, Linkoeping
Phase
Phase 3
Overall status
Completed
Start date
November 15, 2015
Completion date
October 30, 2020
Enrollment
321 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass surgery, heart failure, postoperative complications